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Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is a major hospital- and community-
acquired pathogen, but the mechanisms underlying host-defense to MRSA remain poorly
understood. Here, we investigated the role of IL-21 in this process. When administered intra-
tracheally into wild-type mice, IL-21 induced granzymes and augmented clearance of pulmonary
MRSA but not when neutrophils were depleted or a granzyme B inhibitor was added.
Correspondingly, IL-21 induced MRSA killing by human peripheral blood neutrophils.
Unexpectedly, however, basal MRSA clearance was also enhanced when IL-21 signaling was
blocked, both in Il21r KO mice and in wild-type mice injected with IL-21R-Fc fusion-protein. This
correlated with increased type I interferon and an IFN-related gene signature, and indeed anti-
IFNAR1 treatment diminished MRSA clearance in these animals. Moreover, we found that IFNb
induced granzyme B and promoted MRSA clearance in a granzyme B-dependent fashion. These
results reveal an interplay between IL-21 and type I IFN in the innate immune response to MRSA.
DOI: https://doi.org/10.7554/eLife.45501.001
Introduction
Staphylococcus aureus is a pathogenic bacterium responsible for a high percentage of hospital-
acquired infections as well as for an increasing incidence of community-acquired skin and soft-tissue
infections and secondary infections during pulmonary viral infections such as influenza
(Robinson et al., 2015). The emergence of the highly virulent USA 300 lineage of strains of methicil-
lin-resistant S. aureus (MRSA) has complicated efforts to control infections in immunocompromised
patients as well as in healthy individuals (Mediavilla et al., 2012; Rigby and DeLeo, 2012). Neutro-
phils play a key role in host defense to pulmonary S. aureus infection and are critical for clearance of
MRSA (Parker and Prince, 2012a; Rigby and DeLeo, 2012). Neutrophils are recruited to the lung
and contribute to the immune response, along with proinflammatory cytokines, chemokines, and
other anti-microbial mediators released by lung epithelial cells and resident and incoming innate
immune cells (Rigby and DeLeo, 2012). This response can lead to tissue injury, compromising
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pulmonary integrity and function, thereby promoting the pathogenesis of S. aureus pneumonia
(Parker et al., 2016; Parker and Prince, 2012a).
Interleukin-21 was first identified as a T-cell derived cytokine with pleiotropic actions on lymphoid
cells. Along with IL-2, IL-4, IL-7, IL-9, and IL-15, IL-21 shares the common cytokine receptor g chain
(Asao et al., 2001; Leonard, 2001), gc, which is mutated in humans with X-linked severe combined
immunodeficiency (XSCID) (Noguchi et al., 1993), and defective IL-21 signaling substantially
accounts for the defective B-cell function that is observed in XSCID patients (Ozaki et al., 2002;
Recher et al., 2011), corresponding to IL-21’s ability to promote terminal B cell differentiation to
plasma cells (Ozaki et al., 2004). IL-21 also can promote the differentiation of Th17 cells
(Korn et al., 2007; Nurieva et al., 2007; Zhou et al., 2007), is required for the normal development
of T follicular helper cells (Vogelzang et al., 2008) and optimal Th2 responses to helminth infection
(Fro¨hlich et al., 2007; Pesce et al., 2006), has potent activity as an anti-tumor agent (Skak et al.,
2008; Spolski and Leonard, 2014), and promotes the development of a range of autoimmune dis-
eases (Bubier et al., 2009; Kwok et al., 2012; Spolski et al., 2008), suggesting that blocking IL-21
may be a therapeutic approach in such diseases. Indeed, the effectiveness of JAK3 inhibitors in auto-
immune disease presumably at least partially relates to the inhibition of IL-21 signaling.
IL-21 has also been shown to control both humoral and adaptive cellular responses to viral infec-
tions. For example, IL-21 is critical for the host response to chronic LCMV infection, as viral-specific
CD8+ T cell responses are impaired in Il21r KO mice (Elsaesser et al., 2009; Fro¨hlich et al., 2009;
Yi et al., 2009). Moreover, although humoral immune responses to viral infection could initially
develop in the absence of IL-21, the generation of long-lived plasma cell responses was defective in
the absence of IL-21 (Rasheed et al., 2013). Previously, we found that IL-21 promotes the patho-
logic immune response to infection with Pneumonia Virus of Mice (PVM), which is highly related to
human Respiratory Syncytial Virus (RSV), with enhanced neutrophil recruitment and acute respiratory
distress (Spolski et al., 2012). In PVM, lung CD4+ T cells constitutively express IL-21, and the num-
ber of IL-21+ CD4+ T cells increases following viral infection. Besides its effects on lymphoid cells, IL-
21 exerts effects on non-lymphoid cell types, including inhibiting dendritic cell function and inducing
the apoptosis of conventional DCs (Brandt et al., 2003; Wan et al., 2013); however, a role for IL-21
in innate neutrophil-mediated responses to pulmonary bacterial infection has not been reported. In
light of the fact that human neutrophils have been reported to express IL-21R (Takeda et al., 2014),
we explored the regulation of anti-bacterial responses by IL-21. Here, we investigated the ability of
IL-21 to control a pulmonary model of MRSA infection.
Results
IL-21 enhances MRSA killing in the lungs of WT mice
To investigate the role for IL-21 in the response to a pulmonary bacterial infection, WT mice were
intratracheally (i.t.) infected with the USA 300 strain of MRSA, which induced a significant increase in
Il21 mRNA (Figure 1A) and IL-21 protein (Figure 1B) in the lung 24 hr after infection. Moreover,
using Il21-mCherry reporter transgenic (TG) mice, we found that lung CD4+ T cells had low basal
mCherry expression, but the percentage (Figure 1—figure supplement 1, A and B) and total num-
ber (Figure 1—figure supplement 1C) of Il21-mCherry expressing cells increased after infection
with MRSA. IL-21 production was also significantly induced in CD4+ T cells cultured in the presence
of Staphylococcal enterotoxin B (SEB) (Figure 1—figure supplement 1D), suggesting that bacterial
products can directly induce IL-21 production by this T cell population. Interestingly, treatment of
WT mice with IL-21, as opposed to PBS, prior to intratracheal infection with MRSA resulted in a mod-
est but significant increase in pulmonary clearance of bacteria at both 7 and 24 hr (Figure 1C; see
summary of 6 independent experiments at 7 hr; Figure 1—figure supplement 1E). When we exam-
ined lung pathology, as expected, MRSA infection led to increased lung pathology compared to
uninfected mice, but IL-21 treatment resulted in reduced lung pathology and neutrophil infiltration
at 24 hr as compared to PBS-treated animals (Figure 1D, see insets; Figure 1E) at this time point.
When we quantified neutrophils by flow cytometry, we found that IL-21-treated animals had more
lung neutrophils than PBS-treated animals at 7 hr, but fewer lung neutrophils than PBS-treated mice
at 24 hr (Figure 1F), consistent with the PBS vs. IL-21 effects on histology at this time point
(Figure 1D). The specificity of the IL-21 effect was confirmed by the observation that IL-21 treatment
Spolski et al. eLife 2019;8:e45501. DOI: https://doi.org/10.7554/eLife.45501 2 of 27
Research article Immunology and Inflammation
Ctrl MRSAI
L
-2
1
 (
p
g
/m
l)
 x
 1
0
-2
0
1
2
3 ***
7 h 24 h
C
F
U
/l
o
b
e
 (
1
0
6
)
0
5
10
15
**
**
P
a
th
o
lo
g
y
 s
c
o
re
0
1
2
3
4
*
PBS IL-21
***
IF
N
(p
g
/m
l)
10
100
1000
10000
PBS IL-21
***
G
ra
n
z
y
m
e
B
 (
p
g
/m
l)
0
50
100
150
200
PBS IL-21
***
G
z
m
a
/R
p
l7
.00
.02
.04
.06
.08
.10
Gzma
PBS IL-21
***
G
z
m
b
/R
p
l7
.000
.002
.004
.006
.008
.010
Gzmb
A C
E
7 h 24 h
D Naive MRSA + PBS MRSA + IL-21
7 h
24 h
Ifng
Ifit3
Ifit1
Cxcl9
Cxcl10
P
B
S
IL
-2
1
P
B
S
IL
-2
1
7 h 24 h
Ccl3
Ngp
Muc5b
Clca3
Gzmb
Gzma
GB
F
H I J
R
e
la
ti
v
e
 I
l2
1
m
R
N
A
 (
x
 1
0
-4
)
Ctrl MRSA
1
.5
0
4
2
3
K
Retnla
Reg3g
Ifi44
Oasl2
Gbp1
***
T
o
ta
l 
n
e
u
tr
o
p
h
ils
7 h 24 h
** **
Figure 1. IL-21 enhances killing of pulmonary MRSA in WT mice. (A, B) Intra-tracheal infection with the USA 300 strain of MRSA induced a significant
increase in pulmonary Il21 mRNA (A) and IL-21 protein (B) 24 hr after infection. (C) PBS or 2 mg of IL-21 was administered i.t. to WT mice one day prior
to MRSA infection, and lung MRSA CFU were quantitated 7 and 24 hr later. (D, E) Lung immunopathology was assessed in H and E-stained sections of
lung tissue from naı¨ve uninfected mice and mice pre-treated with PBS or IL-21 and then infected for 7 or 24 hr with MRSA (in upper left panel, the
Figure 1 continued on next page
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of Il21r KO mice did not significantly affect MRSA clearance (Figure 1—figure supplement 1F).
Interestingly, treatment of naı¨ve mice with IL-21 in the absence of MRSA infection induced an
increased accumulation of cells in the BAL fluid (Figure 1—figure supplement 2A) and lung (Fig-
ure 1—figure supplement 2B), and a substantial percentage of the infiltrating cells were neutrophils
(Figure 1—figure supplement 2C). This was accompanied by enhanced levels of the chemokines
CXCL1 and MCP-1 (Figure 1—figure supplement 2D and E), both of which are involved in the
recruitment of myeloid cells.
To investigate the mechanism by which IL-21 enhanced MRSA killing, we next performed RNA-
Seq analysis using RNA from total lung tissue from mice that were treated with PBS or IL-21 prior to
infection with MRSA. By 7 hr after infection of mice pre-treated with IL-21, we observed differential
expression of a range of genes, including those encoding the cytolytic proteases granzyme A
(Gzma) and granzyme B (Gzmb) as well as genes involved in chemoattraction (Ccl3), mucus hyper-
production (Muc5b, Clca3), and anti-microbial defense (e.g., Retnla, Reg3g, Ifi44, Oasl2, Gbp1, and
Ngp) (Figure 1G and Supplementary file 1) (Dietert et al., 2014; Zanin et al., 2016). At 24 hr after
MRSA infection, lungs from IL-21-pre-treated mice expressed Ifng mRNA and interferon-induced
mRNAs (Ifit1, Ifit3) as well as transcripts for major interferon-inducible chemokines involved in
recruitment of myeloid and lymphoid cells (Cxcl9, Cxcl10) (Figure 1G). We used RT-PCR to confirm
IL-21-induced expression of Gzma and Gzmb mRNAs in the lung at 7 hr after infection (Figure 1H
and I), and IL-21-induced granzyme B and IFNg protein production was detected by ELISA in bron-
choalveolar lavage fluid at 7 hr after infection (Figure 1J and K).
IL-21 induces granzyme-mediated MRSA killing by neutrophils
Because the analysis of lung pathology revealed a significant infiltration of neutrophils early after
MRSA infection as compared to uninfected mice (Figure 1D and F), we next investigated the spe-
cific response of neutrophils to IL-21. Previously, human peripheral neutrophils were reported to
either not express (Pelletier et al., 2004) or to express IL-21R (Takeda et al., 2014). Consistent with
the latter report, mouse bone marrow neutrophils (Ly6G+CD11b+) expressed low levels of surface
IL-21R as assessed by flow cytometry. Interestingly, IL-21R expression was enhanced by treatment
with peptidoglycan (Figure 2A and Figure 2—figure supplement 1A), a component of the S. aureus
cell wall. Thus, S. aureus components can induce expression of the IL-21 receptor (Figure 2A) as
well as the IL-21 ligand (Figure 1A and B). To determine whether IL-21-induced clearance of MRSA
required neutrophils, WT mice were treated with anti-Ly6G to deplete neutrophils (Figure 2B) and
then given PBS or IL-21 i.t. prior to MRSA infection. Although IL-21 treatment significantly reduced
the MRSA titer in the lung 24 hr after infection of isotype control-treated mice, it had less of an
effect on MRSA clearance in the neutrophil-depleted mice (Figure 2C). Consistent with a major role
for neutrophils in MRSA clearance, neutrophil-depleted lungs had significantly higher CFU than lungs
not subjected to neutrophil depletion, including in the PBS-treated animals (Figure 2C). The remain-
ing smaller effect of IL-21 on MRSA clearance in the absence of neutrophils might be due to effects
of IL-21 on phagocytosis by macrophages (Vallie`res and Girard, 2013) or dendritic cell
survival (Wan et al., 2013). Although IL-21 enhanced Gzma and Gzmb mRNA expression in isotype
control treated mice, it no longer did so when neutrophils were depleted by anti-Ly6G treatment,
Figure 1 continued
bar = 500 mm and inset bar = 10 mm) (D), and pathology (E) scores were assessed. (F–K) animals were infected with MRSA as above. (F) Total lung
neutrophil cellularity was quantitated by flow cytometry after staining with Ly6G and CD11b. (G) RNA-Seq analysis was performed on total lung tissue
mRNA (pools of 5 animals) isolated 7 or 24 hr after treatment of WT mice with PBS or IL-21. Boxed regions include genes mentioned in the text. (H–K)
RT-PCR was used to assess expression of Gzma (H) and Gzmb (I) mRNA in lungs treated with IL-21 for 7 hr, and ELISA was used to assess the induction
of granzyme B (J) and IFNg protein (K) in corresponding bronchoalveolar lavage fluid at 7 hr. Data are representative of either three (A, B, C, F, H–K) or
two (D, E, G) independent experiments and validation of RNA-Seq was performed by RT-PCR of mRNA from additional mice.
DOI: https://doi.org/10.7554/eLife.45501.002
The following figure supplements are available for figure 1:
Figure supplement 1. IL-21 is expressed in the lung before and after MRSA infection.
DOI: https://doi.org/10.7554/eLife.45501.003
Figure supplement 2. Effects of IL-21 on naı¨ve lung.
DOI: https://doi.org/10.7554/eLife.45501.004
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Figure 2. IL-21-mediated granzyme production and MRSA killing by lung neutrophils. (A) Bone-marrow neutrophils were purified by negative selection
using a neutrophil isolation kit (Miltenyi) and either not stimulated or stimulated in vitro with IL-21 (100 ng/ml) for 24 hr in the absence (control) or
presence of peptidoglycan (PG) (2 or 5 mg/ml); IL-21R expression on gated Ly6G+CD11b+ neutrophils was detected by flow cytometry (blue = isotype
control; red = anti-IL-21R). (B, C) IL-21 lowers the MRSA CFU in a neutrophil-dependent fashion. Mice were treated i.p. with an isotype control mAb or
Figure 2 continued on next page
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implicating neutrophils as a major source of these IL-21-induced transcripts in MRSA-infected mice
(Figure 2D and E). Basal Gzma and Gzmb mRNA levels were higher in lung tissue in animals treated
with anti-Ly6G as compared to isotype control antibody; the basis for the apparent increase in these
transcripts after neutrophil depletion is unclear.
To confirm that Gzma and Gzmb mRNAs were specifically induced by IL-21’s interaction with its
receptor on lung neutrophils, WT and Il21r KO mice were treated with IL-21 for 7 hr, and highly puri-
fied (>98%) FACS-sorted lung neutrophils were analyzed by RT-PCR; indeed, Gzma and Gzmb
mRNAs were induced by IL-21 in neutrophils from WT but not Il21r KO mice (Figure 2F). To further
assess whether granzymes were involved in IL-21-mediated clearance of MRSA, WT mice were
primed intratracheally with heat-killed S. aureus (HKSA), and recruited lung neutrophils were purified
24 hr later (Figure 2—figure supplement 1B). IL-21 could induce expression of both Gzma and
Gzmb mRNA (Figure 2G and H) and augmented MRSA killing by these cells in vitro (Figure 2I),
whereas this IL-21-induced killing was prevented when a granzyme B inhibitor, Z-AAD-CMK, was
added (Figure 2I).
IL-21 also induces a cytolytic profile in human neutrophils
Analogous to the effects of IL-21 on mouse neutrophils, highly purified (>99%) human peripheral
blood neutrophils that showed no evidence of contamination by NK or CD8 T cells (Figure 3—figure
supplement 1A) expressed IL21R mRNA and expression was further induced by stimulation with IL-
21 (Figure 3A), and we furthermore found that surface IL-21R protein expression was modestly
enhanced by stimulation with IL-21 (Figure 3B, left and right panels). Moreover, when we performed
RNA-Seq analysis on highly purified human neutrophils that were either not stimulated or stimulated
with IL-21, consistent with our observations in IL-21 treated mice, GZMA, GZMB, GNLY (encoding
granulysin), PRF1 (encoding perforin) mRNAs were all induced more than 2-fold by IL-21, and this
was observed whether or not cells were exposed to heat-killed S. aureus (HKSA) (Figure 3C and
Supplementary file 2). We confirmed the induction of GZMA, GZMB, and GNLY by RT-PCR
(Figure 3D-F). Moreover, although IFNG mRNA induction did not quite meet the FC >2 criterion
and thus was not included in Figure 3C, expression of this gene was highly induced by IL-21, as
assessed by RT-PCR (Figure 3G). Interestingly, IL-21 treatment did not appreciably alter the expres-
sion of intracellular granzyme B protein detected by flow cytometry in permeabilized cells
(Figure 3H, left and right panels), but it significantly increased the release of granzyme B protein
into the supernatant of purified human peripheral blood neutrophils, as assessed by ELISA
(Figure 3I). To further analyze production of granzyme B by neutrophils, we used western blotting.
Levels of granzyme B from >99% enriched neutrophils were lower than in an equivalent number of
PBMC (Figure 3—figure supplement 1B), but PBMC contamination could not account for the signal
from purified neutrophils, as even a 1% level of PBMCs gave no detectable signal when added to
A549 cells, which do not express detectable Granzyme B, and even a 5% PBMC addition was still
less than the signal from the >99% enriched neutrophils (Figure 3—figure supplement 1B). Cou-
pled to flow cytometry (Figure 3H) and the failure of IL-21 to induce Gzmb mRNA after neutrophil
Figure 2 continued
neutrophil-depleted with anti-Ly6G (1A8 mAb), and the efficacy of neutrophil depletion is shown in BAL and lung (B). Mice were then treated with PBS
or IL-21 i.t., infected i.t. with MRSA, and CFU quantitated at 24 hr (C). CFU quantitation was performed on the left single lobe, whereas immune
populations and RNA were determined using the right lobes. (D, E) Levels of Gzmb and Gzma mRNAs in lung tissue of untreated or neutrophil-
depleted mice (treated as in panel C) were quantitated by RT-PCR. (F) Levels of Gzma and Gzmb mRNAs in purified cell-sorted lung neutrophils (>98%
pure Ly6G+CD11b+) from either untreated or IL-21-treated WT or Il21r KO mice were measured by RT-PCR and normalized to Rpl7 expression. (G, H)
Lung neutrophils were elicited by i.t treatment with heat-killed S. aureus 24 hr prior to isolation, purified, stimulated in vitro for 4 hr with either PBS or
IL-21 (100 ng/ml), and Gzma (G) and Gzmb (H) mRNAs assayed by RT-PCR and normalized to Rpl7 expression. (I) Purified HKSA-elicited lung
neutrophils were incubated in vitro with MRSA for 3 hr in the presence of PBS or IL-21 either without or with the granzyme B inhibitor, Z-AAD-CMK.
MRSA CFU was quantitated by plating serial dilutions on blood agar plates. Representative experiments are shown; each experiment was performed
three times with similar results.
DOI: https://doi.org/10.7554/eLife.45501.005
The following figure supplement is available for figure 2:
Figure supplement 1. Purity of neutrophil preparations.
DOI: https://doi.org/10.7554/eLife.45501.006
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Figure 3. Human neutrophils express IL-21R, and IL-21 induces a program that leads to granzyme B-dependent neutrophil-mediated killing of MRSA.
(A, B) Purified peripheral blood neutrophils were stimulated with PBS (control) or IL-21 (100 ng/ml) for 4 hr, and IL21R mRNA was measured by real-time
PCR and normalized to RPL7 expression (A), and IL-21R protein levels were measured by flow cytometry (B); left panel shows isotype control shaded
and anti-IL21R black line, with a summary in the right panel). (C) RNA-Seq was performed on neutrophils after 4 or 24 hr incubation with PBS or IL-21 in
Figure 3 continued on next page
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depletion of mice (Figure 2E), this further supports production of granzyme B by these cells (see
Discussion). A previous report had shown enhanced reactive oxygen species (ROS) in response to
zymosan plus IL-21 (Takeda et al., 2014). However, IL-21, either alone or in combination with HKSA,
did not significantly enhance intracellular ROS production (Figure 3—figure supplement 2), sug-
gesting that increasing ROS is not a major mechanism by which IL-21 augmented the killing of
MRSA. Although granzymes A and B were originally characterized based on their roles in T cell and
NK cell-mediated killing of target cells (Voskoboinik et al., 2015), these proteases and anti-micro-
bial peptides can promote the killing of a number of types of bacteria as well (Walch et al., 2014).
IL-21 also induced expression of the CCL2 gene (Figure 3C), which encodes MCP1, a chemokine
that recruits additional innate cells to sites of infection (Balamayooran et al., 2011). Thus, IL-21
induces a transcriptional program in human neutrophils that enhances their cytotoxic potential and
leads to further recruitment of innate immune cells. Because IL-21 enhanced release of granzyme B,
we investigated if IL-21 stimulation could enhance in vitro killing of MRSA by these cells. Indeed,
purified peripheral human blood neutrophils stimulated with IL-21 consistently reduced the number
of MRSA (Figure 3J). Moreover, IL-21 also induced clearance of Streptococcus pyogenes by human
neutrophils (Figure 3K), indicating that the effect was not restricted to a single pathogen.
Unexpected enhanced MRSA clearance and lung inflammation in Il21r
KO mice
Because IL-21 augmented MRSA clearance, we hypothesized that Il21r KO mice, as compared to WT
mice, would exhibit defective bacterial killing and thus a greater CFU when infected with MRSA.
Unexpectedly, however, when mice were infected i.t. with MRSA, although no difference was
observed at 4 hr, the bacterial burden in the lungs of Il21r KO mice at 24 hr was significantly lower
than that observed in WT mice (Figure 4A), indicating greater clearance of the bacteria. To confirm
this finding, we next directly compared in a single experiment the levels of MRSA killing for WT ver-
sus Il21r KO mice and for WT mice treated with PBS versus IL-21, and indeed, as compared to
untreated WT mice, Il21r KO mice and IL-21-treated WT mice both had lower MRSA CFUs
(Figure 4B). To further evaluate the ability of WT vs. Il21r KO mice to handle MRSA, we examined
the inflammatory response. In WT mice, infection with Pneumonia Virus of Mice (PVM), in which host
defense substantially depends on adaptive immunity, results in a marked inflammatory response by
5 or 6 days, and we previously showed that this is substantially diminished after infection of Il21r KO
mice (Spolski et al., 2012). In contrast, with MRSA infection, in which host defense significantly
depends on a neutrophil-mediated innate immune response, Il21r KO mice had greater inflammation
than WT mice, and this was already evident at 4 and 24 hr (Figure 4C, see magnified insets), with an
increased pathology score at both time points (Figure 4D). Interestingly, when infiltrating neutro-
phils were isolated and counted, both IL-21-treated WT mice (see Figure 1F) and Il21r KO mice
(Figure 4E) had more neutrophils than untreated WT mice at the early time point but fewer
Figure 3 continued
the absence or presence of heat-killed S. aureus (106/ml). We used HKSA rather than live bacteria in order to allow analysis at 24 hr, as live bacteria
would have overgrown the system by then. Genes differentially expressed (fold-change >2.0) are shown. Shown is a representative RNA-Seq analysis. (D
– G) Human peripheral blood neutrophils were stimulated for 4 hr in vitro in the presence or absence of IL-21 and GZMA (D), GZMB (E), GNLY (F), and
IFNG (G) mRNA levels were quantitated by RT-PCR and normalized to RPL7 expression. (H) Purified human neutrophils were stimulated with IL-21 for 4
hr, fixed, permealized, and stained for intracellular granzyme B protein (gated on CD66b+ cells); MFIs are summarized in right panel. (I) Granzyme B
protein was measured by ELISA in supernatants from human peripheral blood neutrophils cultured for 24 hr in either the absence or presence of IL-21
(100 ng/ml). (J, K) Human neutrophils were incubated in vitro with either MRSA (J) or S. pyogenes (K) for 3 hr with PBS or IL-21 (100 ng/ml). MRSA and
S. pyogenes CFU were quantitated by plating serial dilutions on blood agar plates. Results shown are representative of 3 independent experiments,
except panel C shows one of two similar independent RNA-Seq experiments, each from a different donor.
DOI: https://doi.org/10.7554/eLife.45501.007
The following figure supplements are available for figure 3:
Figure supplement 1. Purity of human neutrophils.
DOI: https://doi.org/10.7554/eLife.45501.008
Figure supplement 2. Reactive oxygen species were measured by flow cytometry in CellRox Red loaded peripheral blood neutrophils that were
stimulated at 37˚C for 30 min with PBS, IL-21, HKSA, or HKSA +IL-21.
DOI: https://doi.org/10.7554/eLife.45501.009
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Figure 4. Pulmonary MRSA infection is cleared more efficiently in Il21r KO than in WT mice and this requires neutrophils. (A) WT and Il21r KO mice
were infected intratracheally with MRSA (2  107) and CFU in the lung were quantitated at 4 and 24 hr post-infection. (B) WT and Il21r KO mice were
infected in parallel with WT mice that had been treated with PBS or 2 mg IL-21, and CFU in the lung were quantitated at 7 and 24 hr post infection. (C–
E) Lung immunopathology was assessed in H and E-stained lung sections (bar in upper left panel = 500 mm; bar in inset = 10 mm) (C); lung neutrophil
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neutrophils than untreated WT mice at 24 hr; this is potentially reflective of the better clearance of
MRSA in the Il21r KO mice by 24 hr (Figure 4A). Note that the higher pathology score at 24 hr
(Figure 4D) is not inconsistent with the lower total neutrophil count at that time point (Figure 4E),
as the pathology score is not limited to neutrophil numbers but rather to the severity of lung lesions
in involved areas. WT lungs at 24 hr showed only focal lesions, mostly seen at perivascular areas with
mild inflammation. These inflammatory cells consist of neutrophils, lymphocytes and macrophages.
However, KO lung at 24 hr showed diffuse lesions with alveolitis and numerous neutrophils, lympho-
cytes, and macrophages. Neutrophils were important for the enhanced anti-bacterial activity
observed in Il21r KO mice, as neutrophil depletion prevented the enhanced clearance of MRSA
(Figure 4F).
Type I interferons contribute to the enhanced MRSA clearance by Il21r
KO mice
To investigate the molecular mechanism(s) underlying the enhanced MRSA clearance in Il21r KO
mice, we used RNA-Seq to compare gene expression patterns in WT versus Il21r KO lungs at 4 and
24 hr after MRSA infection (Figure 5A and Supplementary file 3). Of the 1474 differentially-
expressed genes, 664 were downregulated and 810 were upregulated in the Il21r KO mice
(Figure 5A). Some of the genes that were most increased in the Il21r KO lung at both time points
are known to be regulated by type I and type II IFNs, including multiple members of the Gbp
(Gbp1, Gbp2, Gbp3, Gbp4, Gbp6, Gbp8, Gbp10) and Ifi (Ifi44, Ifi45, Ifit1, Ifit2, Ifit3) families
(Figure 5B and Supplementary file 3), which mediate responses to bacterial and viral infections
(Berry et al., 2010; Yamamoto et al., 2012). Analysis of the top five upstream regulators of the
most differentially expressed genes identified the type I IFN receptor (IFNAR1) and IFNg as being
key pathways in the differential regulation of transcripts in Il21r KO versus WT cells (Figure 5C).
Moreover, the IFNl receptor (IFNLR1) and miR-21, a target of type 1 and 3 IFNs (Liu et al., 2017;
Yang et al., 2010), were also identified (Figure 5C). To determine whether the local production of
type I IFNs might account for the gene expression profile seen in the RNA-Seq analysis, we mea-
sured IFNa protein levels by ELISA in bronchoalveoar lavage (BAL) fluid at 4 hr after MRSA infection,
and levels were higher in the Il21r KO than in the WT samples (Figure 5D). The higher IFNa in the
Il21r KO BAL correlated with better MRSA clearance in Il21r KO than in WT mice (lower CFU); how-
ever, blocking with anti-IFNAR1 raised the CFU for both WT and KO mice to similar levels
(Figure 5E), supporting the idea that an augmented type I IFN response in the Il21r KO mice
(Figure 5D) indeed was responsible for their enhanced MRSA killing (Figure 5E, left). Pre-treatment
with anti-IFNAR1 had only a modest effect on lung cellularity (not achieving statistical significance)
(Figure 5F). Moreover, besides increasing the CFU for WT and Il21r KO mice to a similar level
(Figure 5E), anti-IFNAR1 treatment also blocked the enhanced expression of interferon-regulated
genes, Gbp1 and Oasl1, in lungs from Il21r KO mice (Figure 5G and H).
Blocking pulmonary IL-21 signaling phenocopies the enhanced
antimicrobial activity of Il21r KO mice
It was possible that the enhanced MRSA killing in the Il21r KO mice was a developmentally-acquired
phenotype rather than directly resulting from defective IL-21 signaling. We therefore intratracheally
administered IL-21R-Fc fusion protein into WT mice for two days prior to MRSA infection to acutely
block IL-21R-dependent signaling. Analogous to the Il21r KO mice, WT mice receiving IL-21R-Fc had
greater clearance of MRSA at both 4 and 24 hr after infection than was observed in mice treated
with the control Fc (Figure 6A). Moreover, histological analysis of lung sections showed that mice
treated with IL-21R-Fc had enhanced inflammation (Figure 6B) and significantly increased pathology
and neutrophil scores by 4 hr after infection (Figure 6—figure supplement 1, A and B), analogous
Figure 4 continued
cellularity as assessed by pathology score (D) and flow cytometry (E) were assessed at 4 and 24 hr post-infection. (F) WT or Il21r KO mice were pre-
treated with an isotype control antibody or anti-Ly6G to deplete neutrophils, infected with MRSA, and CFU quantitated at 24 hr. Representative
experiments are shown; each experiment was performed three times with similar results.
DOI: https://doi.org/10.7554/eLife.45501.010
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Figure 5. RNA-Seq analysis revealed an enhanced IFN profile in Il21r KO lungs. (A) Venn diagram showing the number of differentially expressed genes
(1474) in WT vs Il21r KO lungs, with 664 genes downregulated and 810 genes upregulated in the Il21r KO. (B) Heat map showing a cluster of IFN-
related genes more highly expressed in Il21r KO than in WT lung. (C) Pathway analysis of differentially expressed genes shows enrichment for IFN-
related genes. (D) IFNa was measured by ELISA in BAL fluid from WT and Il21r KO mice 4 hr after infection with MRSA. (E) Diminished MRSA killing in
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to what we observed above in the Il21r KO mice (Figure 4D and E). Moreover, increased IFNa pro-
tein was detected at 4 hr in the BAL fluid of mice receiving IL-21R-Fc (Figure 6C), analogous to the
increased IFNa we had detected in the BAL fluid of Il21r KO mice (Figure 5D). Consistent with
increased type I interferon production, RNA-Seq analysis of mRNA from lungs of MRSA-infected
mice that were treated with the IL-21R-Fc fusion protein revealed augmented expression of mRNAs
for a range of genes regulated by type I or type II interferons, as compared to mice treated with the
control Fc (Figure 6—figure supplement 1C and Supplementary file 4). Thus, the absence of IL-21
signaling, as occurred in lungs from both Il21r KO mice and WT mice treated with IL-21R-Fc, led to
an augmented interferon-responsive gene signature and enhanced MRSA killing.
The fact that there was enhanced IL-21-induced granzyme-mediated MRSA killing in WT mice
and yet also enhanced killing in the absence of IL-21 signaling prompted us to further examine how
the increased levels of type I interferon might explain the enhanced MRSA killing in the Il21r KO
mice and in WT mice treated with the IL-21R-Fc fusion protein. Interestingly, at 24 hr after MRSA
infection, the Il21r KO mice had higher levels of Gzmb mRNA in lung tissue compared to WT mice,
and treatment of mice with an anti-IFNAR1 blocking antibody reduced Gzmb mRNA in the Il21r KO
lungs to WT levels (Figure 6D). WT mice pre-treated with IL-21R-Fc prior to MRSA infection also
had elevated levels of lung Gzmb mRNA at both 4 and 24 hr (Figure 6E). Moreover, IFNb not only
enhanced GZMB mRNA expression by purified normal human neutrophils to a similar degree as did
IL-21 (Figure 6F), but it also induced killing of MRSA in a granzyme-dependent manner given that a
significant decrease in CFU was no longer observed when a GZMB inhibitor was added (Figure 6G).
Thus, both IL-21 and type I interferon appear to induce similar cytotoxic programs and to augment
killing of MRSA.
The enhanced type I interferon responses that we observed when IL-21 signaling was absent or
impaired suggested an inverse correlation between IL-21 and IFNa/b levels during the response to
MRSA infection. We explored this possibility using an in vitro system in which both cytokines could
be produced. Specifically, we examined the response of CD4+ T cells and bone marrow-derived den-
dritic cells in a mixed lymphocyte response (MLR) to the SEB superantigen. Although the addition of
SEB with control Fc induced Il21 mRNA production by CD4+ T cells in this MLR (Figure 6H), the
addition of IL-21R-Fc augmented the effect. Interestingly, dendritic cell production of type I IFN
mRNAs (Ifna2 and Ifnb) was inhibited by SEB (Figure 6I and J); importantly, IL-21 is at least partially
responsible for inhibiting type I IFN production, as addition of IL-21R-Fc fusion protein instead of
control Fc diminished or reversed the inhibition (Figure 6I and J). It has previously been demon-
strated that IFNa in combination with either IL-12 or TCR activation can enhance expression of IL-21
in human NK and T cells and downregulate IL-21R expression on these cells (Strengell et al., 2004),
in keeping with the functional interaction of these two signaling pathways.
IL-21 does not enhance MRSA killing by neutrophils from AD-HIES
patients
To further investigate the mechanism of IL-21-induced killing of MRSA, because IL-21 signals in part
via STAT3, we next used neutrophils from patients with autosomal dominant hyper-IgE syndrome
(AD-HIES) or Job’s syndrome, a disease caused by autosomal dominant mutations in STAT3 that
result in STAT3 deficiency, with increased susceptibility to fungal and bacterial infections, including
S. aureus (Freeman and Holland, 2008). When peripheral blood neutrophils from three healthy
donors and six patients were assayed in a MRSA killing assay, IL-21 significantly lowered the CFU
with cells from all normal donors (ND1, ND2, ND3), but it did not significantly lower the CFU in
experiments using cells from any of the AD-HIES patients (PT1-PT6; Figure 7A). In fact, two of the
six patients (PT3 and PT4) had higher basal MRSA killing than did the corresponding normal donor,
Figure 5 continued
lungs at 24 hr in mice pre-treated with anti-IFNAR1. (F) Total lung cellularity at 24 hr in mice pre-treated with Ctrl IgG or anti-IFNAR; the differences
observed were not statistically significant at p<0.05. (G, H) Blocking type I IFN signaling with anti-IFNAR1 prior to infection with MRSA prevented
enhanced expression of Gbp1 (G) and Oasl1 (H) mRNAs at 24 hr in Il21r KO lungs. Expression was normalized to Rpl7, Representative results from one
of 2 independent RNA-Seq experiments are shown in panel A-C; in D-H, each experiment was performed three times with similar results.
DOI: https://doi.org/10.7554/eLife.45501.011
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Figure 6. Blocking IL-21 signaling with IL-21R-Fc in WT mice phenocopies the enhanced MRSA killing seen in Il21r KO mice. (A) WT mice were treated
intratracheally with 50 mg of control Fc (from IgG1) or IL-21R-Fc protein for 2 days prior to infection with MRSA and lung CFU were quantitated at 4 and
24 hr post-infection with MRSA. (B) Histology of lungs in control Fc or IL-21R-Fc pre-treated mice at 4 and 24 hr post-infection (bar in upper left
panel = 500 mm; bar in inset = 10 mm). (C) IFNa levels in BAL fluid were measured by ELISA 4 hr after infection in mice pretreated with control Fc or IL-
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ND2 (see ‘PBS’ lanes in Figure 7A, middle panel). Interestingly, all six patients had much lower
GZMB mRNA levels, including in response to IL-21, as compared to the three normal donors
(Figure 7B). Whereas the basis for this lower basal GZMB expression in the AD-HIES patients is
unclear, these results indicate that STAT3 deficiency diminished IL-21-mediated enhancement of
GZMB expression.
In light of the enhanced interferon responses in mice lacking IL-21R signaling, we next examined
whether purified neutrophils from AD-HIES patients had altered interferon responses. RNA-Seq anal-
ysis was performed using either normal donor or AD-HIES neutrophils stimulated for 4 hr with IL-21,
IFNb, or both cytokines (Figure 7C and Supplementary file 5). Interestingly, AD-HIES patient neu-
trophils had significantly enhanced expression of a cluster of IFNb-responsive genes, as compared to
normal donor neutrophils (Figure 7C), and we confirmed by RT-PCR that GBP1 and GBP2 were
induced in neutrophils from additional donors as well (Figure 7D). These observations are consistent
with higher expression of IFN-related genes in Il21r KO than in WT mice (Figure 5B).
A mouse model of AD-HIES with a Stat3 mutant transgene corresponding to a mutation found in
a patient with AD-HIES has been shown to mimic the characteristics of AD-HIES patients (Steward-
Tharp et al., 2014). Accordingly, we treated these transgenic mice with IL-21 prior to i.t. MRSA
infection and then analyzed the mice 7 hr after infection. Analogous to our observations of defective
MRSA killing by highly purified neutrophils from AD-HIES patients examined in vitro (Figure 7A), IL-
21 did not enhance MRSA killing in these Stat3 mutant transgenic mice (Figure 7E). Interestingly,
however, these mice had enhanced basal killing of pulmonary MRSA in the absence of IL-21 as com-
pared to the corresponding WT mice (Figure 7E, compare the PBS-treated samples). Consistent
with an inverse relationship between IL-21 signaling and IFNa levels following infection with MRSA,
IFNa levels were elevated in both serum (Figure 7F) and BAL fluid of the Stat3 mutant mice
(Figure 7G). Although there presumably are effects of STAT3 deficiency in addition to the IFN-
related connection, our results collectively indicate that the absence of a functional STAT3-mediated
immune response correlates with an amplified type I interferon response and that this contributes to
the augmented killing observed in this setting (Figure 8).
Discussion
In this study, we demonstrate that IL-21 can act directly on neutrophils and promote an anti-micro-
bial program that leads to the clearance of pulmonary bacterial pathogens. Interestingly, IL-21 aug-
ments expression of the IL-21R on neutrophils and additionally upregulates expression of granzyme
A, granzyme B, and perforin in enriched human peripheral blood neutrophils and mouse lung neu-
trophils, with enhanced cytotoxic activity against MRSA and S. pyogenes. In human cells, granzymes
A and B are delivered to target cells by granulysin, which we show is also induced by IL-21 in human
neutrophils, and these enzymes can kill bacteria through cleavage of enzymes that promote oxida-
tive damage, thereby preventing the oxidative stress response (Walch et al., 2014). Interestingly,
granzyme B was also reported to contain a peptide sequence with bactericidal activity against S.
aureus (Shafer et al., 1991). The idea that granzymes are expressed by neutrophils has been contro-
versial (Grossman and Ley, 2004; Hochegger et al., 2004; Metkar and Froelich, 2004), with some
studies not identifying these proteins and others collectively detecting their expression in
Figure 6 continued
21R-Fc. (D) Gzmb mRNA was measured in lungs of WT or Il21r KO mice pre-treated with isotype control or anti-IFNAR1 antibodies prior to MRSA
infection, and normalized to Rpl7 mRNA expression. (E) Gzmb mRNA was measured in lungs of mice treated with either control Fc or IL-21R-Fc prior to
MRSA infection and normalized to Rpl7 expression. (F) Like IL-21, IFNb also induced GZMB mRNA in human peripheral blood neutrophils and
normalized to RPL7 expression. (G) IFNb induces increased in vitro killing of MRSA by human peripheral blood neutrophils and this was prevented by a
granzyme B inhibitor, Z-AAD-CMK. (H–J) Co-cultures of CD4+ T cells and dendritic cells were stimulated with SEB either in the presence of control Fc
or IL-21R-Fc, and mRNA was quantitated by RT-PCR after 24 hr and normalized to Rpl7 expression. Representative experiments are shown; each
experiment was performed three times with similar results.
DOI: https://doi.org/10.7554/eLife.45501.012
The following figure supplement is available for figure 6:
Figure supplement 1. Pathology and RNA-Seq analysis of lungs from mice treated with control Fc or IL-21R-Fc prior to i.t.
DOI: https://doi.org/10.7554/eLife.45501.013
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Figure 7. Neutrophils from patients with autosomal dominant hyper-IgE syndrome (AD-HIES) display reduced ex vivo IL-21-induced MRSA cytotoxic
function. (A) Peripheral blood neutrophils from normal donors (NDs) or AD-HIES patients (PTs) were assayed using an in vitro MRSA killing assay in the
absence or presence of IL-21 (100 ng/ml). (B) RT-PCR was used to quantitate GZMB mRNA in neutrophils 4 hr after in vitro stimulation without or with
IL-21. Expression was normalized to RPL7 expression (C) RNA-Seq was performed on normal donor and AD-HIES patient neutrophils stimulated for 4 hr
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neutrophils by confocal microscopy, western blotting, and ELISA, and subcellular fractionation has
localized granzymes to primary neutrophil granules (Hochegger et al., 2007; Wagner et al., 2004;
Wagner et al., 2008). Moreover, our data indicate that intracellular granzyme B is expressed by neu-
trophils, that its release is induced by IL-21, that depletion of neutrophils decreases IL-21-mediated
induction of Gzmb mRNA in the lung thereby implicating these cells as a source of these transcripts,
and that a granzyme inhibitor blocks the IL-21-induced lowering of MRSA CFU. Interestingly, gran-
zyme B-expressing neutrophils were detected in lung granulomas from humans and macaques in
association with M. tuberculosis infection (Mattila et al., 2015). IL-21 has also been shown to be crit-
ical in the adaptive immune response to M. tuberculosis (Booty et al., 2016), suggesting a multi-fac-
eted IL-21-mediated response to pulmonary microbial infection. Our observation that granzyme B
was released by neutrophils after IL-21 stimulation in vitro is consistent with reports of a neutrophil-
mediated extracellular proteolytic activity on either extracellular matrix components (Boivin et al.,
2009) or components of the innate complement system (Perl et al., 2012) that may more broadly
regulate disease pathology. Human B cells have also been shown to release granzyme B in response
to co-stimulation by the B cell receptor and IL-21 (Hagn et al., 2009). Thus, IL-21 and granzymes
appear to play roles in early responses to pathogens by both innate and adaptive immune cells.
Cleavage of IL-1a by secreted granzymes has been shown to enhance the biological activity of this
cytokine both in vitro and in vivo, thus adding to the potential functions for secreted granzymes
(Afonina et al., 2011).
Although IL-21 augmented MRSA killing, to our surprise both Il21r KO mice and WT mice treated
with an IL-21R-Fc fusion protein also displayed higher pulmonary MRSA clearance than untreated
WT mice. This conundrum is at least in part explained by our demonstrating that chronic absence of
IL-21 signaling (Il21r KO) or even short-term inhibition of IL-21 signaling (treatment with IL-21R-Fc
fusion protein) is accompanied by an enhanced type I interferon response in the lung, with increased
granzyme B expression and neutrophil anti-microbial action. Although type I IFNs can regulate CD8
cytolytic activity via the induction of granzyme B (Kohlmeier et al., 2010) and as noted above, gran-
zyme B-expressing neutrophils were reported in lung granulomas following infection with M. tuber-
culosis (Mattila et al., 2015), to our knowledge an interplay between type I IFNs and granzymes in
neutrophil anti-microbial action has not been reported. The effects of type I IFN on bacterial infec-
tion can be either beneficial or detrimental, depending on the particular bacterium and the context
of potential co-infection with a virus (Stifter and Feng, 2015; Trinchieri, 2010). Here, we show that
type I IFN promoted killing of MRSA and that this was inhibited by a granzyme B inhibitor. Previous
studies have shown that S. aureus induces a type I IFN signal in dendritic cells via TLR9 (Parker and
Prince, 2012b), and that Ifnar1 KO mice were protected from MRSA infection compared to WT
mice and preferentially survived a lethal dose of MRSA. Our results demonstrate that type I IFN
induction of granzyme B can mediate MRSA clearance, and experiments using anti-IFNAR1 in WT
mice reduced clearance of MRSA. This implies a potential difference between mice developmentally
deficient in expression of receptor for type I IFNs versus acute blockade of IFN signaling. In addition
to the effects of type I IFN on MRSA clearance, our RNA-Seq analysis identified type III IFN receptor
(IL-28R) as one of the upstream regulators of the enhanced killing by Il21r KO mice. Interestingly,
type III IFN receptor KO mice were also resistant to MRSA, displaying reduced inflammation and
lower expression of inflammatory cytokines and yet no reduction in recruitment of neutrophils to the
lung (Cohen and Prince, 2013). Some of these effects of type III IFN are mediated by deficient neu-
trophil serine protease cleavage of IL-1b precursor (Pires and Parker, 2018). Thus, compensatory
changes in cytokines or cell populations in both type I and type III IFN receptor KO mice may
account for differences seen with mice in which IFN is acutely blocked by anti-IFNAR1.
IL-21 signals mainly via STAT3 (Kwon et al., 2009; Zeng et al., 2007), often in the context of
large transcription factor complexes comprising AP1 and IRF4 (Ciofani et al., 2012;
Figure 7 continued
with PBS, IL-21, IFNb, or IL-21 +IFNb. Genes differentially expressed (fold-change >1.5) in two independent RNA-Seq analyses are shown. (D) RT-PCR
normalized to RPL7 expression was used to validate the expression pattern of GBP1 and GBP2 in neutrophils from additional normal donors and AD-
HIES patients. (E–G) Mutant Stat3 transgenic mice were treated i.t. with PBS or 2 mg IL-21, infected i.t. 24 hr later with MRSA, and at 7 hr post-infection
lung MRSA CFU quantitated (E), and IFNa levels were measured in the serum (F) and BAL fluid (G).
DOI: https://doi.org/10.7554/eLife.45501.014
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Figure 8. A model for the functional interplay of IL-21 with type I interferons in the response to MRSA. (A) In wild-type (WT) mice, MRSA produces SEB,
which bridges between T cells and dendritic cells by interacting with TCR and MHCII, leading to the production of IL-21 by CD4+ T cells. IL-21
stimulates neutrophils to release granzymes, with enhanced killing of MRSA. Type I IFN (e.g., produced by dendritic cells, as shown in the cartoon) can
also induce granzyme production to promote killing of MRSA, but IL-21 inhibits dendritic cell production of type I IFN. (B) In the absence of either IL-
Figure 8 continued on next page
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Glasmacher et al., 2012; Li et al., 2012); it also more weakly can activate and signal via STAT1
(Wan et al., 2015; Zeng et al., 2007), with sometimes opposing effects of STAT1 and STAT3 (62).
Type I interferons dominantly activate STAT1/STAT2/IRF9 (ISGF3) complexes; thus, it is possible that
type I interferons and IL-21 might functionally compete given the enhanced expression of type I IFN-
regulated transcripts in Stat3 KO T follicular helper cells (Ray et al., 2014). Moreover, STAT3 has
been shown to negatively regulate type I IFN-mediated anti-viral responses (Wang et al., 2011b).
Importantly, we showed that IL-21-induced granzyme B responses were defective in cells from
STAT3-deficient AD-HIES patients, which could relate to the recurrent infections that occur in these
individuals, including with S. aureus (Freeman and Holland, 2008; Holland et al., 2007), and fur-
thermore, AD-HIES neutrophils had defective IL-21-induced MRSA cytotoxic activity in vitro. The fail-
ure of AD-HIES patients to produce a functional Th17 response is consistent with studies
demonstrating the defective clearance of S. aureus from the lungs of Il17r or Il22 KO mice
(Kudva et al., 2011), and this may to be dependent on reduced anti-microbial function of lung epi-
thelial cells (Minegishi et al., 2009). However, although IL-21 can be produced by Th17 effector
cells, IL-21 production in the lung could be dominated by T follicular helper cells, independent of
local production of IL-17, and in fact, IL-17 production can be independent of STAT3 (St Leger
et al., 2018). Interestingly, neutrophils from some AD-HIES patients had enhanced IL-21-indepen-
dent in vitro MRSA cytotoxic activity, which could potentially relate to the augmented STAT1
responses that have been observed in CD4+ T cells (Wan et al., 2015) and neutrophils
(Holland et al., 2007) from these patients. However, not all of the AD-HIES patients’ neutrophils
had enhanced in vitro MRSA cytotoxic activity, potentially reflecting patient heterogeneity and dif-
ferences in recent infections/medical history. However, when we used a mutant Stat3 transgenic
mouse model for AD-HIES (Steward-Tharp et al., 2014), we uniformly found increased levels of
type I IFN in both serum and BAL fluid after MRSA infection, suggesting a possible mechanism for
the enhanced MRSA killing/lower CFU observed with neutrophils from some AD-HIES patients as
well as from the AD-HIES-like Stat3 mutant transgenic mice. It is also conceivable, however, that the
compensatory increase in the type I IFN program observed in the absence of IL-21 signaling or
STAT3 expression may involve IL-21-mediated inhibition of type I IFN expression by dendritic cells,
as we observed in our in vitro experiments with SEB. It is important to recognize that multiple cyto-
kines besides IL-21 can also activate STAT3, and some of the STAT3-mediated effects on MRSA
clearance are known to depend on signaling by IL-6 in the lung epithelial compartment (Choi et al.,
2013). Nevertheless, our results with Il21r KO mice and IL-21R-Fc treated WT mice indicate that the
specific absence of IL-21-induced STAT3 signaling can lead to a compensatory interferon-mediated
cytotoxic program.
IL-21 can have both pro-inflammatory or anti-inflammatory functional roles, depending on the cel-
lular context and cytokine milieu (Spolski and Leonard, 2014), but our current findings importantly
extend the known actions of IL-21, particularly related to neutrophil biology and bacterial infection.
Our data suggest that IL-21 may not only serve a protective role during pulmonary bacterial infection
but also indicate potentially complex homeostatic regulation of the IL-21 versus the type I IFN anti-
microbial program, given that the latter is associated with blocking IL-21. These studies underscore
the potential complexity of the role of IL-21 in host defense, and further studies are needed to
understand how the effects of IL-21 related to neutrophils can integrate with actions of IL-21 on
other immune cells. Given that both administering IL-21 (for cancer) and blocking IL-21 (for autoim-
mune disease) are of potential clinical interest in humans (Spolski and Leonard, 2014), it is impor-
tant to be cognizant of possible effects on host defense of modulating levels and the actions of this
cytokine.
Figure 8 continued
21R or a functional STAT3 signaling response, the IL-21-induced neutrophil granzyme production does not occur. However, IL-21-mediated repression
of type I IFN production by dendritic cells also no longer occurs, which leads to enhanced production of type I IFN and hence increased killing of
MRSA through this pathway. The functional cross-talk of and relative potency of the IL-21- and type 1 IFN-mediated pathways and levels of each
cytokine influence the outcome.
DOI: https://doi.org/10.7554/eLife.45501.015
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Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain,
strain background
(S. aureus)
FPR3757 ATCC ATCC BAA-1556
Strain,
strain
background
(Streptococcus
pyogenes)
NZ131 ATCC ATCC-BAA-1633
Genetic
reagent (M.
musculus)
Il21r-/- Ozaki et al.
Science
298:1630,
2002
Genetic
reagent (M.
musculus)
mCherry Il21 Wang et al.
P.N.A.S.
108:9542,
2011
Genetic
reagent (M.
musculus)
C57BL/6-Tg(Stat3*)
9199Alau/J
Jackson
Laboratory
Stock # 027952
Biological
sample (S.
aureus)
Staph
enterotoxin B
List Biological
Laboratories
#122
Biological
sample (S.
aureus)
Heat-killed
S. aureus
In Vivo Gen tlrl-hksa
Antibody Mouse monoclonal
anti-granzyme
B
Biolegend GB11
RRID:AB_
2562195
flow
cytometry 1:100
Antibody Mouse monoclonal
anti-granzyme
B
Biolegend clone
M3304B06
RRID:AB_
2565266
WB (1:500)
Antibody Mouse monoclonal
anti-Ly6G (1A8)
BioX Cell RRID: AB_1107721 Blocking Ab
Antibody Mouse monoclonal
anti-IFNAR (MAR1-5A3)
BioX Cell RRID: AB_2687723 Blocking Ab
Antibody Mouse
monoclonal
MOPC-21
BioX Cell RRID: AB_1107784 Blocking Ab
Antibody Rat
monoclonal
2A3
BioX Cell RRID: AB_1107769 Blocking Ab
Antibody Mouse monoclonal
anti-human
IL21
BD Biosciences clone
3A3-N2.1
RRID:AB_
2738933
flow
cytometry 1:100
Antibody Rat
monoclonal
anti-mouse
IL-21R
BD Biosciences clone 4A9 flow
cytometry 1:100
Antibody Mouse monoclonal
anti-human
IL-21R
Biolegend clone
2G1-K12
RRID:AB_
2123988
flow
cytometry 1:100
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody Mouse monoclonal
anti-human CD66b
Biolegend clone
G10F5
RRID:AB_
2563294
flow cytometry 1:100
Antibody Mouse monoclonal
anti-CD11b
Biolegend clone M1/70
RRID:AB_
312789
flow cytometry 1:100
Peptide,
recombinant
protein
Recombinant
mouse IL-21
R and D
Systems
594 ML-100/CF
Peptide,
recombinant
protein
Recombinant
human IL-21
R and D
Systems
8879-IL-050/CF
Peptide,
recombinant
protein
Recombinant
human GM-CSF
R and D
Systems
215 GM
Peptide,
recombinant
protein
Recombinant
human IL-4
R and D
Systems
204-IL
Peptide,
recombinant
protein
Z-AAD-CMK Enzo Life
Sciences
BML-P165
Commercial
assay or kit
IL-21 ELISA R and D
Systems
DY594
Commercial
assay or kit
Granzyme
B ELISA
Ebioscience BMS2027
RRID:AB_
2575322
Commercial
assay or kit
IFNalpha
ELISA
Ebioscience 50-246-672
Commercial
assay or kit
Cell Rox Deep
Red staining kit
InVitrogen/
Molecular Probes
C10491
Commercial
assay or kit
Mouse
neutrophil
isolation kit
Miltenyi 130-097-658
Commercial
assay or kit
Human neutrophil
isolation kit
Stem Cell
Technologies
19666
Commercial
assay or kit
KAPA
stranded
mRNA-Seq
library kit
Kapa Biosystems KK8580
Chemical
compound,
drug
Peptidoglycan
from S. aureus
Sigma #77140
Mice
Sex-matched littermate WT and Il21r KO mice were analyzed at 8–12 weeks of age. mCherry-IL-21
reporter mice have been described (Wang et al., 2011a). Transgenic mice expressing a mutant
Stat3 that corresponds to mutations found in AD-HIES patients (Steward-Tharp et al., 2014) were
obtained from the Jackson Laboratory. All experiments were performed under protocols approved
by the National Heart, Lung, and Blood Institute Animal Care and Use Committee and followed
National Institutes of Health guidelines for use of animals in intramural research.
Intratracheal inoculation with S. aureus and S. pyogenes
The USA 300 clinical isolate (FPR3757) of MRSA or the S. pyogenes NZ131 strain were used for all
experiments. S. aureus bacteria were grown overnight at 37˚C in a shaking incubator in tryptic soy
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broth, diluted 1:10, and mid-logarithmic growth phase bacteria were obtained after an additional 2
hr of culture. S. pyogenes were grown in Todd Hewitt Broth under static conditions. Bacteria were
pelleted and washed twice with PBS. Bacterial concentrations were estimated by measuring absor-
bance at 600 nm, and the absolute CFU was determined by plating dilutions on blood agar plates.
For infection, mice were lightly anesthetized with ketamine/xylazine and received an intratracheal
instillation of 50 ml of S. aureus (2  107 CFU). For neutrophil depletion experiments, mice were
injected i.p. with 1 mg 1A8 (anti-Ly6G) mAb or 2A3 isotype control mAb 2 days prior to MRSA infec-
tion. For blocking type I interferon responses, mice were injected with 1 mg MAR1-5A3 (anti-
IFNAR1) or MOPC-21 isotype control mAbs on each of 2 days prior to infection. All depletion anti-
bodies and isotype controls were from BioXCell. S. aureus were quantified after infection by homog-
enizing one lung lobe in 1 ml PBS, followed by plating serial dilutions on blood agar plates.
IL-21
We primarily used human and mouse IL-21 from R and D Systems. However, we confirmed key
results with IL-21 from Peprotech as well.
Mouse lung neutrophil isolation and MRSA killing assay
WT mice were treated intratracheally with 2  107 heat-killed S. aureus (HKSA, InVivoGen). Lung
cells were isolated after one day by digestion with collagenase (1 mg/ml) and DNaseI (1 mg/ml) and
were enriched first on a 44%/67% Percoll gradient. Neutrophils were then purified (80–90%) with a
mouse neutrophil isolation kit (Miltenyi Biotec) and were used directly in either MRSA killing assays
or were in vitro stimulated with IL-21 and then RNA isolated for RT-PCR analysis.
Mixed lymphocyte cultures
Mouse splenic CD4+ T cells were purified with a Stem Cell Technologies negative selection CD4+ T
cell isolation kit and co-cultured with bone marrow-derived dendritic cells (cultured with GM-CSF for
7 days) at 1:1 ratio with or without Staphylococcal entertoxin B (SEB, 0.05 mg/ml, List Biological Lab-
oratories,>95% pure, 14 EU/mg) and in the presence of either IL-21R-Fc blocking agent or control
Fc (20 mg/ml) for 24 hr; RNA was then isolated. For intracellular staining of IL-21, human CD4+ T cells
were purified from peripheral blood (Dynabeads Untouched negative selection CD4+ T cell kit, Invi-
trogen) and co-cultured at a 5:1 ratio with monocyte-derived DCs that had been cultured for 6 days
in GM-CSF (800 U/ml) plus IL-4 (400 U/ml). At 72 hr, cultures were treated with Golgi Plug for 4 hr
and stained for detection of intracellular IL-21 (clone 3A3-N2.1) by flow cytometry.
Human neutrophil isolation and MRSA killing assay
Whole blood from healthy donors was collected and neutrophils isolated by negative selection using
a direct neutrophil isolation kit (Stem Cell Technologies), yielding purity of >99%. For MRSA killing
assays, 4  105 neutrophils were incubated in RPMI medium with PBS or IL-21 (100 ng/ml), followed
by the addition of 50 ml of MRSA (at a 1:1800 dilution of an optical density at 600 nm
(OD600) = 0.25) pre-incubated in 10% autologous serum. For granzyme B inhibition, neutrophils
were pre-incubated for 20 min with 100 mM Z-AAD-CMK (Enzo Life Sciences). Tubes were rotated at
37˚C for 3 hr, and serial dilutions then spread on blood agar plates, incubated overnight, and CFU
determined. De-identified whole blood from healthy volunteer donors from the NIH Department of
Transfusion Medicine was obtained and met the Office of Human Subjects Research criteria for a
waiver for the need for IRB approval.
Histology
Lungs were inflated before excision, fixed in 10% formalin, embedded in paraffin, and then 5 mm
sections were cut and slides were stained with H and E. Clinical scores for pathology and cellular
infiltration were independently evaluated by the pathologist.
Flow cytometry
Whole human blood was incubated at 37˚C with either PBS or IL-21 for 3 hr, fixed with warm Phos-
Flow Fixative (BD Biosciences), washed twice with FACS buffer and then stained with anti-human IL-
21R (2G1-K12) (Biolegend) or isotype control mAbs. For intracellular granzyme B staining, human
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neutrophils were purified by sequential LymphoSep and neutrophil purification kit (Stem Cell Tech-
nologies), cultured with medium or IL-21 for 4 hr, washed, incubated with human Fc receptor block-
ing antibodies (BioLegend) for 15 min, and then stained with either CD66b or CD11b with live/dead
stain included. Cells were fixed for 30 min, washed with permeabilization buffer (EBioscience FoxP3
staining buffer kit), and stained for 1 hr with PacBlue anti-granzyme B (clone GB11; Biolegend) or
isotype control diluted in permeabilization buffer. Bone marrow neutrophils were isolated with nega-
tive selection kits (Miltenyi) to >90–95% purity. Mouse bone marrow neutrophils were cultured over-
night with IL-21 (R and D Systems) and peptidoglycan (Sigma) prior to IL-21R staining using 4A9
mAb (BD Biosciences). Neutrophils were pretreated with 0.5% acetic acid containing 0.5 M NaCl for
30 s to strip cytokine binding prior to staining with anti-IL-21R antibodies (BD Biosciences). Samples
were collected using a BD FACS Canto II and analyzed using Flow Jo software.
ROS staining of neutrophils
100 ml of cells were suspended in RPMI medium containing 10% FBS and 100 ml (5 mM) of Cell ROX
Deep Red was added. Cells were incubated at 37˚C for 30 min in medium without or with cytokine,
washed twice with PBS, fixed for 15 min at room temperature in 4% paraformaldehyde, and washed
twice with FACS buffer. Cells were then surface-stained as usual, washed two times in FACS buffer,
and analyzed on a BD FACS Canto II flow cytometer.
RNA preparation and RNA-Seq
RNA was extracted from lung tissue using Trizol (Invitrogen) and the RNeasy kit (Qiagen). Quantita-
tive RT-PCR was performed using the Omniscript reverse transcription kit, and amplification was per-
formed using the Veriquest PCR master mix and specific Taqman probes from Applied Biosystems.
Expression relative to the human RPL7 or mouse Rpl7 ‘housekeeping’ gene was calculated using the
Delta Delta Ct method. RNA sequencing was performed using the KAPA Stranded mRNA-Seq
Library Preparation kit (Kapa Biosystems) following the manufacturer’s instructions using an Illumina
HiSeq 2000 or HiSeq 2500 platform (Illumina, San Diego, CA). Sequenced reads (50 bp, single end)
were mapped to the mouse genome (NCBI37/mm9, July 2007) using Bowtie 0.12.9, and only the
reads that mapped onto exons of each RefSeq gene were measured and normalized using reads per
kilobase per million mapped reads. Analyses of differential gene expression were performed using R
package edgeR.
ELISAs
Bronchoalveolar lavage fluid was obtained by flushing the lungs through the trachea with 1 ml PBS.
IL-21 was quantitated using an ELISA kit (R and D Systems). Granzyme B was measured using either
human or mouse specific ELISA systems (eBioscience), and interferon-a was measured using a mouse
specific ELISA that recognizes all subtypes of IFN-a (eBioscience).
Western blotting for granzyme B
Neutrophils were purified as above, stimulated for 4 hr without or with IL-21 in the presence of pro-
tease inhibitor (cOmplete tablets, Roche; one tablet/10 ml). Cells were pelleted at 4˚C, washed two
times with cold PBS (+PI), and resuspended in Pierce RIPA buffer (+PI). Cells were kept on ice for 30
min with periodic mixing, and extracts were cleared at high speed for 15 min at 4˚C. Extracts (10–20
mg/lane) were then run under reducing conditions on an SDS gel (NuPAGE 4–12% Bis-Tris). Western
blotting was performed with mouse anti- human granzyme B monoclonal antibody (Biolegend clone
M3304B06, final concentration of 1 mg/ml), followed by incubation with goat anti-mouse (IRDye
680RD, Licor) and imaging on an Odyssey CLx.
Statistical analysis
Two-tailed t tests (nonparametric Mann-Whitney) were performed using Prism (GraphPad). For all
statistical analysis. Data were considered significant when p < 0.05 (*), p < 0.01 (**), p < 0.001 (***),
or p < 0.0001 (****).
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